Senior insider sale
Chief Executive Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$133.1K
15.38K shares
What this filing means
TOWNSEND RICHARD NOLAN plans to sell 15.38K shares of LEXEO THERAPEUTICS, INC. valued at approximately $133.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/18/2025ACC: 0001959173-25-007105
DirectorOfficer· Chief Executive Officer
Since Feb 2026
15.38K
Shares to sell
$133.1K
Approx. market value
1.13K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
11/17/2025
1.13KTotal acquired1.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/17/2025 | Restricted Stock Vesting Compensation | 1.13K | — |
| Total | 1.13K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
13.13K
Market value
$117.4K
10/17/2025
—Completed
Units to sell
1.11K
Market value
$5.2K
8/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.13K
Market value
$10.5K
11/18/2025
Total
Units
15.38K
Value
$133.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/17/2025 | 13.13K | $117.4K | — | Completed |
8/18/2025 | 1.11K | $5.2K | — | Completed |
| Planned — Approximate Date | ||||
11/18/2025 | 1.13K | $10.5K | NASDAQ | Planned |
| Total | 15.38K | $133.1K | ||